Should I Buy MCS? MCS 2026 Analysis

Should You Buy Marcus Corp (MCS) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion

Hold

Latest Price

15.010

1 Day change

-0.40%

52 Week Range

22.380

Analysis Updated At

2026/01/30

Not a good buy right now for an impatient buyer. The technical trend is bearish (negative/expanding MACD, bearish MA stack SMA200>SMA20>SMA5) and there are no near-term news catalysts to flip momentum. While options positioning is call-skewed (bullish sentiment), the very high implied volatility suggests expensive/uncertain pricing rather than a clean directional setup. With weakening YoY fundamentals in 2025/Q3, I would avoid chasing an entry here and wait for either a clear trend reversal above ~15.50–16.03 or a capitulation/reclaim pattern off support.

Technical Analysis

Trend/Momentum: Bearish. MACD histogram is negative (-0.0762) and expanding lower, indicating downside momentum is strengthening. Moving averages are bearishly aligned (SMA_200 > SMA_20 > SMA_5), consistent with a downtrend. RSI(6) at 36.6 is weak (near oversold but not showing a reversal signal). Key levels: Pivot 15.498 is immediate overhead resistance; price (15.07) is below pivot, which keeps bias negative. Near-term support is S1 14.963 (very close); if that breaks, next support S2 14.633. Resistance levels: R1 16.033 then R2 16.363. Pattern-based forward bias (similar candlesticks): 60% chance of -1.34% next day, +0.47% next week, +1.53% next month—near-term downside risk dominates, with only modest upside odds beyond that. Intellectia Proprietary Trading Signals - [AI Stock Picker](module://ai_stock_pick): No signal on given stock today. - [SwingMax](module://swingmax): No signal on given stock today.

Options Data

Bullish

Open Interest Put-Call Ratio

Bullish

Option Volume Put-Call Ratio

Sentiment/positioning: Put/Call OI ratio at 0.23 indicates materially more call open interest than puts (bullish skew). Put volume is 0 today and call volume is 12, reinforcing a short-term call-leaning tape. Volatility/pricing: 30D IV ~78.76 with IV percentile 90 suggests options are very expensive versus recent history, typically reflecting heightened uncertainty and making directional long-premium trades less attractive. Overall: sentiment skews bullish via calls, but the high IV implies the market is charging heavily for that exposure.

Technical Summary

Sell

Buy

Positive Catalysts

and pushes toward 16.
Price is near first support (14.963); a clean hold-and-reclaim above pivot could trigger a short-term mean-reversion bounce.

Neutral/Negative Catalysts

reflects elevated uncertainty and can accompany sharp moves, especially if support (14.
fails.

Financial Performance

Latest quarter: 2025/Q3. Growth trends weakened YoY: Revenue 199.516M (-10.24% YoY), Net Income 16.23M (-30.39% YoY), EPS 0.52 (-28.77% YoY). Gross margin 36.59% (down ~3.28% YoY). Overall, fundamentals show decelerating top-line and more pronounced profit/EPS compression, which is not supportive of aggressive buying without a technical reversal or catalyst.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No analyst rating or price target change data was provided, so a current Wall Street pros/cons summary cannot be reliably derived from the dataset. From the available fundamentals/price action alone: Pros would be potential mean-reversion near support and call-skew sentiment; cons are deteriorating YoY financials and a clearly bearish trend.

2 Analyst Rating

Wall Street analysts forecast MCS stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for MCS is 23.5 USD with a low forecast of 22 USD and a high forecast of 25 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

2 Buy

0 Hold

0 Sell

Moderate Buy

Current: 15.070

Low

Averages

23.5

High

Current: 15.070

Low

Averages

23.5

High

Wedbush

Outperform

initiated

$24

AI Analysis

2025-07-18

Reason

Wedbush

Price Target

$24

AI Analysis

2025-07-18

initiated

Outperform

Reason

Wedbush initiated coverage of Marcus with an Outperform rating and $24 price target. The firm sees the company benefiting from a more consistent theatrical release slate over the next several quarters. Marcus is positioned to to raise its dividend back toward pre-pandemic rates and repurchase shares, the analyst tells investors in a research note. Wedbush adds that Marcus has room to monetize surplus real estate as it owns most of its properties. It has a positive bias on the shares.

B. Riley

Buy

downgrade

$26 -> $24

2025-05-16

Reason

B. Riley

Price Target

$26 -> $24

2025-05-16

downgrade

Buy

Reason

B. Riley lowered the firm's price target on Marcus to $24 from $26 and keeps a Buy rating on the shares following a transfer of coverage. The firm is "generally constructive" on the exhibitor space, saying the sector is underpinned by a strong Hollywood film slate for 2025 and 2026 that should fuel further box office recovery and benefit relevant industry participants. Riley also finds limited tariff risk and a history of movie-going resiliency during periods of economic weakness "to be additional market themes that are supportive of this favorable backdrop." The firm's top pick across the group is Imax (IMAX), followed by Marcus (MCS).

Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for MCS

Unlock Now

MCS Should I Buy

MCS Should I Buy

Should You Buy Marcus Corp (MCS) Today? Analysis, Price Targets, and 2026 Outlook.

Technical Analysis

Options Data

Technical Summary

Positive Catalysts

Neutral/Negative Catalysts

Financial Performance

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

People Also Watch